Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02365064 · ClinicalTrials.gov registry record · NA

CPAP vs ASV for Insomnia

A NA study, sponsored by ResMed.

Completed
Registry status
NA
Development phase
78
Enrollment target

NCT02365064: Completed NA study, sponsored by ResMed.

NCT02365064 is a NA study that has completed, run by ResMed. The registered enrollment target is 78 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02365064, a NA study, has completed, sponsored by ResMed.

COMPLETED
Registry status
NA
Development phase
78 participants
Enrollment target

Study Summary

The study will determine which of two different types of positive airway pressure (PAP therapy) modes are more effective in reducing sleep breathing events in chronic insomnia patients and in decreasing insomnia severity.

Primary Outcome

Change in insomnia severity from baseline to 4 months as measured by subjective questionnaire. The Insomnia Severity Index has seven questions. The seven answers are added up for a total score. Scores range from 0 - 28. A higher score indicates a more severe degree of insomnia.

Interventions

  • DEVICE AirCurve 10 ASV

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2015-02
Est. Completion 2017-12-01
Phase NA
ResMed

25 total trials

What the finished NCT02365064 record still lists

NCT02365064 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 1 intervention - of which AirCurve 10 ASV is the first listed.

NCT02365064 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02365064 about?

NCT02365064 is a clinical study titled "CPAP vs ASV for Insomnia". The study will determine which of two different types of positive airway pressure (PAP therapy) modes are more effective in reducing sleep breathing events in chronic insomnia patients and in decreasing insomnia severity.

What is the current status of trial NCT02365064?

This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2015-02. Estimated completion is 2017-12-01.

What interventions are being tested in trial NCT02365064?

The interventions under investigation include: AirCurve 10 ASV (DEVICE).

Who is sponsoring clinical trial NCT02365064?

This trial is sponsored by ResMed, which has 25 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02365064's enrollment target sits among peer trials

78 1060th of 2000 higher than 939 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02397668 · 78 participants · NA

    CorMatrix Cor TRICUSPID ECM Valve Replacement Study

  • NCT03321656 · 78 participants · Phase 2

    Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile

  • NCT03687814 · 78 participants · NA

    Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation

  • NCT04018872 · 78 participants · Phase 2

    Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02365064, the US trial registry maintained by the National Library of Medicine. NCT02365064 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.